NeuroPace Inc. Files 8-K on Financials
Ticker: NPCE · Form: 8-K · Filed: Mar 4, 2025 · CIK: 1528287
| Field | Detail |
|---|---|
| Company | Neuropace Inc (NPCE) |
| Form Type | 8-K |
| Filed Date | Mar 4, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, operations, filing
Related Tickers: NPCE
TL;DR
NeuroPace filed an 8-K on March 4, 2025, detailing its financial condition and operations.
AI Summary
NeuroPace Inc. filed an 8-K on March 4, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the report date and date of change both being March 4, 2025. The company is incorporated in Delaware and its fiscal year ends on December 31.
Why It Matters
This 8-K filing provides an update on NeuroPace Inc.'s financial condition and operational results, which is crucial information for investors and stakeholders to assess the company's performance.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any immediate negative news or significant changes.
Key Players & Entities
- NeuroPace Inc. (company) — Registrant
- March 4, 2025 (date) — Report Date
- Delaware (jurisdiction) — State of Incorporation
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on NeuroPace Inc.'s Results of Operations and Financial Condition, and to include Financial Statements and Exhibits.
When was this 8-K report filed?
The report was filed on March 4, 2025.
In which state was NeuroPace, Inc. incorporated?
NeuroPace, Inc. was incorporated in Delaware.
What is NeuroPace Inc.'s fiscal year end?
NeuroPace Inc.'s fiscal year ends on December 31.
What is the Commission File Number for NeuroPace, Inc.?
The Commission File Number for NeuroPace, Inc. is 001-40337.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 4, 2025 regarding NeuroPace Inc (NPCE).